已收盤 05-08 16:00:00 美东时间
-0.230
-1.52%
Olema Pharmaceuticals ( ($OLMA) ) has shared an update. On April 27, 2026, Olem...
05-02 06:33
Olema Pharmaceuticals granted stock options for 188,500 shares to four new employees under its 2022 Inducement Plan, effective April 1, 2026. The options vest over four years with a 10-year term and an exercise price of $15.12 per share.
04-02 20:30
Wolfe Research analyst Kalpit Patel initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Peer Perform rating.
03-27 19:56
今日重点评级关注:RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从32美元升至35美元;巴克莱:维持CytomX医疗"超配"评级,目标价从10美元升至16美元
03-20 15:53
今日重点评级关注:花旗:维持Candel Therapeutics"买入"评级,目标价从22美元升至26美元;Chardan Capital:维持CervoMed"买入"评级,目标价从15美元升至21美元
03-19 14:31
Top analysts changed outlook on top names. Mizuho, Needham, Rothschild & Co, HC Wainwright & Co, Stifel, BTIG, Goldman Sachs made changes.
03-18 20:19
今日重点评级关注:韦德布什:维持Black Diamond Therapeutic"跑赢大市"评级,目标价从13美元升至14美元;花旗:维持Olema Pharmaceuticals"买入"评级,目标价从60美元升至62美元
03-18 10:48
Guggenheim analyst Brad Canino maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price target from $40 to $38.
03-17 20:57